Weekly shot may curb Post-Smoking weight gain in overweight adults

NCT ID NCT06173778

First seen Feb 11, 2026 · Last updated May 01, 2026 · Updated 8 times

Summary

This study tests whether a once-weekly injection of semaglutide can limit weight gain in adults with overweight or obesity who are quitting smoking. About 197 participants will receive the drug or a placebo, and researchers will measure changes in body weight, body composition, and appetite control. The goal is to find a way to support smoking cessation without the unwanted weight gain that often follows.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The University of Texas Health Science Center at Houston

    RECRUITING

    Houston, Texas, 77054, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The University of Texas at Austin

    RECRUITING

    Austin, Texas, 78723, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.